MyAverix Finance
TA · Healthcare
Intercure (INCR)
Drug Manufacturers - Specialty & Generic
Intercure (INCR) is listed on TA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for INCR
Intercure (INCR) — FAQ
What is INCR's P/E ratio?
The price-to-earnings (P/E) ratio for Intercure (INCR) is 18.00 (data as of 2026-05-24).
Does Intercure pay a dividend?
Dividend yield is not available in the current snapshot for Intercure (INCR). Check the MyAverix Finance app for the latest dividend data.
What sector is Intercure in?
Intercure (INCR) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is INCR listed on?
INCR is listed on TA.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.